Accueil / Tag Archives: United States

Tag Archives: United States

Granules India to Add 102 Jobs, Invest $35 Million in Fairfax County Pharmaceutical R&D, Manufacturing Operation

Monday, May 22nd 2017 at 2:30pm UTC Hyderabad-based company expanding presence in Chantilly area FAIRFAX COUNTY, Va.–(BUSINESS WIRE)– Governor Terry McAuliffe today announced that Granules India Ltd., a vertically integrated pharmaceutical company, will invest $35 million into its wholly owned subsidiary, Granules Pharmaceuticals Inc., to expand its pharmaceutical R&D and …

Plus »

GlycoMimetics’ GMI-1271 Receives EU Orphan Drug Designation for Acute Myeloid Leukemia

Thursday, May 25th 2017 at 1:25pm UTC ROCKVILLE, Md.–(BUSINESS WIRE)– GlycoMimetics, Inc. (NASDAQ: GLYC) today announced that the European Commission, based on a favorable recommendation from the European Medicines Agency (EMA) Committee for Orphan Medicinal Products, has granted orphan designation for the company’s drug candidate GMI-1271 for the treatment of …

Plus »

Ligand to Participate in Two Upcoming Investor Conferences

Monday, May 22nd 2017 at 1:00pm UTC SAN DIEGO–(BUSINESS WIRE)– Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that company executives are scheduled to participate in the following upcoming investor conferences: 14th Annual Craig-Hallum Institutional Investor Conference in Minneapolis. Conference takes place on Wednesday, May 31, 2017 with one-on-one meetings only. John …

Plus »

Neural Analytics Announces Data that Demonstrates its Portable Transcranial Doppler Technology Can Assess Early Strokes With More than 95 Percent Accuracy

Wednesday, May 24th 2017 at 3:30pm UTC Data Presented at 26th European Stroke Conference LOS ANGELES–(BUSINESS WIRE)– Neural Analytics Inc., a medical device company developing and commercializing technology to measure, diagnose and track brain health, today announced initial results of the EXPEDITE clinical study showing its Transcranial Doppler Technology Platform …

Plus »

Origenis Announces Patent Grants for Lead Small Molecule LRRK2 Inhibitors for Treatment of Neurodegenerative and Inflammatory Diseases

Tuesday, May 23rd 2017 at 12:30pm UTC Strengthens IP position in the US, complements grants in other key markets and protects further development of small molecule drugs capable of penetrating the blood-brain barrier MARTINSRIED, Germany–(BUSINESS WIRE)– Origenis GmbH, a privately held biopharmaceutical company developing novel therapeutics to fight neurodegenerative and …

Plus »

Biologics’ Patient Access Services Team Procures More Than $44 Million in Co-Pay Assistance for Cancer Patients in 2016

Wednesday, May 24th 2017 at 1:00pm UTC Rising costs of cancer care threaten access to treatment for many patients CARY, N.C.–(BUSINESS WIRE)– Biologics, Inc., a McKesson Specialty Health oncology pharmacy services company, secured more than $44 million in co-pay assistance in 2016 for commercial patients in need of oral chemotherapy …

Plus »

Debiopharm International SA Enters the Field of Antibody-Drug Conjugates Through Acquisition of Phase II Asset from ImmunoGen

Tuesday, May 23rd 2017 at 8:01pm UTC Transaction adds innovative clinical-stage program to expanding Debiopharm portfolio and broadens its clinical development expertise Divestiture aligns with ImmunoGen’s focus on strategic growth initiatives and generates near-term value LAUSANNE, Switzerland & WALTHAM, Mass.–(BUSINESS WIRE)– Debiopharm International SA (Debiopharm –, part of Debiopharm Group™, a Switzerland-based …

Plus »

Clovis Oncology Announces Presentations at 2017 ASCO Annual Meeting

Tuesday, May 23rd 2017 at 12:00pm UTC Updates on rucaparib clinical trials in multiple solid tumors and therapy settings at ASCO Annual Meeting; top-line data from ARIEL3 pivotal study anticipated by end of June BOULDER, Colo.–(BUSINESS WIRE)– Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that abstracts highlighting progress in the …

Plus »

Akebia Therapeutics Names Rita Jain, M.D. as Chief Medical Officer

Thursday, May 25th 2017 at 12:30pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible factor (HIF), today announced the appointment of Rita Jain, M.D. as Senior Vice President and Chief Medical Officer. …

Plus »
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
Vous appréciez cet article ? Faites-nous part de vos commentaires.
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
Retrouvez nous sur
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...